Skip to content

Effect of sleep disturbance on the dosage of the general anesthetic drug cyclopofol

Effect of sleep disturbance on the dosage of the general anesthetic drug cyclopofol

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500109249
Enrollment
Unknown
Registered
2025-09-16
Start date
2025-03-07
Completion date
Unknown
Last updated
2025-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep disturbances

Interventions

Sleep disturbance group:NA
Sleep normal group:NA

Sponsors

the first hospital of hebei medical university
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing elective surgery in the First Hospital of Hebei Medical University; 2. Age 40~65 years old; 3. ASA grade II~III; 4. BMI:18.5~28.5kg/m2;

Exclusion criteria

Exclusion criteria: 1. Allergy to study medication; 2. Those with a history of severe heart, liver and kidney diseases, nervous and psychiatric diseases; 3. Central nervous system disease or previous history of cerebrovascular accident; 4. There are conditions at the site where the patient intends to wear the bracelet that affects the wearing of the bracelet or the accuracy of the monitoring data; Such as skin breakage, infection or vascular lesions;

Design outcomes

Primary

MeasureTime frame
Total amount of cyclophenol;

Secondary

MeasureTime frame
General information of the patient (age, BMI, ASA grade, duration of surgery, duration of anesthesia);PSQI scale score;Simplified McGill Pain Questionnaire Score;Dosage of cyclopofol during the induction period;Smart bracelet sleep monitoring;

Countries

China

Contacts

Public ContactWei Yanyan

The First Hospital of Hebei Medical University

49885489@qq.com+86 311 8715 6732

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026